Key Takeaways
- • APEMARS ($APRZ) presale is currently in Stage 15 (RED SPACE) priced at $0.0001967 per token, with an expected listing price of $0.0055, representing a reported 2,600% growth potential from early-stage entry.
- • The presale has attracted 1,580+ token holders, raised over $400,000, and sold 23 billion tokens, positioning it as the only active presale featured among a broader list of 2026 cryptocurrency opportunities.
- • APEMARS incorporates an Orbital Boost Referral System offering 9.34% rewards to both referrer and referred parties after a $22 minimum contribution, designed to incentivize community growth and participation.
- • A $1,000 investment at Stage 15 pricing would yield approximately 5,083,867 APEMARS tokens at current presale rates, representing early-stage exposure before expected public listing.
Summary
The presale metrics indicate developing community interest and capital deployment. Over 1,580 token holders have participated in the offering, with cumulative fundraising exceeding $400,000 and 23 billion tokens distributed to date. These figures position APEMARS as the only active presale included in broader market commentary on 2026 cryptocurrency opportunities, distinguishing it from established coins like Ethereum and Solana.
The project's community-building infrastructure centers on the Orbital Boost Referral System, which provides 9.34% rewards to both referring and referred participants once a $22 minimum contribution threshold is met. This dual-incentive structure is designed to facilitate organic growth through participant networks and lower barriers to entry for community expansion.
For investors evaluating early-stage exposure, the mathematical framework shows that a $1,000 capital allocation at Stage 15 pricing would purchase approximately 5,083,867 APEMARS tokens. As a presale instrument, APEMARS represents early-stage risk exposure distinct from publicly traded cryptocurrency markets, with returns contingent upon successful project development and exchange listing execution.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.